跳至主要内容
临床试验/EUCTR2019-002283-27-GB
EUCTR2019-002283-27-GB进行中(未招募)1 期

A phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose selection study of S-600918 in patients with refractory chronic cough

Shionogi B.V.0 个研究点目标入组 372 人开始时间: 2019年11月18日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Shionogi B.V.
入组人数
372

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Having refractory chronic cough (including unexplained chronic cough) for at least 1 year.
  • - If female and of childbearing potential, agreement to use one of the allowed contraceptive methods.
  • - Capable of giving signed informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 360
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 12

排除标准

  • - Currently smokes or uses potentially irritating inhalational agents (eg, e-cigarettes, smokeless cigarettes, vaping); stopped smoking or using potentially irritating inhalational agents within the last year; or has a smoking history of 20 pack-years or more.
  • - Has chronic obstructive pulmonary disease or uncontrolled asthma.
  • - Has a clinically unstable medical condition.
  • - History of or ongoing significant psychiatric disorder.
  • - History of respiratory tract infection or significant change in lung function or a pulmonary condition in the last 4 weeks.
  • - History of malignancy in the last 5 years.
  • - History of severe drug allergy.
  • - History of alcohol or drug abuse in the last year or currently uses any form of marijuana or illicit drugs.
  • - Has a clinically significant finding on a chest x-ray or chest computed tomography (CT) scan in the last year.
  • - Has systolic blood pressure > 160 mm Hg or diastolic blood pressure > 90 mm Hg.
  • - Received S-600918 previously.
  • - Received an investigational drug in the last 3 months.
  • - Received an angiotensin converting enzyme (ACE) inhibitor in the last 3 months or requires such treatment.
  • - Has a positive serologic test for human immunodeficiency virus (HIV) antigen or antibody, hepatitis B virus surface antigen, or hepatitis C virus ribonucleic acid (RNA).
  • - If female, pregnant or trying to become pregnant or breastfeeding.

研究者

发起方
Shionogi B.V.

相似试验